4-phenylenediamine has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CJ; Lu, SN; Santella, RM; Zhang, YJ | 1 |
| Arai, M; Hagiwara, A; Shibata, MA; Tamano, S; Tsuda, H | 1 |
2 other study(ies) available for 4-phenylenediamine and Liver Neoplasms
| Article | Year |
|---|---|
Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
Topics: Adult; Aflatoxin B1; Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; DNA; DNA Adducts; Female; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Liver Neoplasms; Male; Middle Aged; Phenylenediamines | 1992 |
Lack of modifying effects of p-phenylenediamine on induction of gamma-glutamyl transpeptidase-positive foci in a medium-term bioassay system using F344 rats.
Topics: Animals; Body Weight; Diethylnitrosamine; Drug Interactions; Enzyme Induction; gamma-Glutamyltransferase; Hepatectomy; Injections, Intraperitoneal; Kidney; Liver; Liver Neoplasms; Male; Organ Size; Phenylenediamines; Rats; Rats, Inbred F344 | 1990 |